Loading provider…
Loading provider…
Hematology & Oncology Physician in Florence, AL
NPI: 1053348037Primary Employer
Oncology Specialties, P.C.
clearviewcancer.com
HQ Phone
Get MD Clint's Phone Numberphone_androidMobile
Get MD Clint's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTN State Medical License
AL State Medical License
MO State Medical License
2006 - 2026
TN State Medical License
2012 - 2026
AL State Medical License
2003 - 2025

American Board of Internal Medicine
Hematology

American Board of Anesthesiology
Hospice and Palliative Medicine

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Medical Oncology

American Board of Internal Medicine
Hospice and Palliative Medicine
University of Missouri-Columbia
Fellowship • Hematology and Medical Oncology
2006 - 2008
Heersink School of Medicine - Birmingham
uab.edu
Medical School
Until 2001
University of Alabama Hospital
2005 - 2006
University of Tennessee
Fellowship • Hematology and Medical Oncology
2004 - 2005
University of Alabama Medical Center (Montgomery)
Residency • Internal Medicine
2001 - 2004
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 706 | 2,079 |
| 2 | 36415Insertion of needle into vein for collection of blood sample | 692 | 1,995 |
| 3 | 80053Blood test, comprehensive group of blood chemicals | 686 | 1,871 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 446 | 1,269 |
| 5 | 83550Iron binding capacity | 375 | 750 |
Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Non-Squamous Non–Small-Cell Lung Cancer
Authors: Heather Wakelee, William Lawler, Tarek Mekhail, Thomas Lowe
Publication Date: 2017-01
Lead Sponsor: Eli Lilly and Company
Collaborators: NSABP Foundation Inc
Intervention / Treatment: DRUG: Abemaciclib, DRUG: Standard Adjuvant Endocrine Therapy